Article

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic…

Journal of Diabetes Research · 2018 · Wenjuan Liu, author Wei Gong, author Min He, author Yemei Liu, author Yeping Yang, author Meng Wang, author Meng Wu, author Shizhe Guo, author Yifei Yu, author Xuanchun Wang, author Fei Sun, author Yiming Li, author Linuo Zhou, author Shengmei Qin, author Zhaoyun Zhang, author Ilaria Campesi, Academic Editor

Key facts

Title Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
First author Wenjuan Liu, author Wei Gong, author Min He, author Yemei Liu, author Yeping Yang, author Meng Wang, author Meng Wu, author Shizhe Guo, author Yifei Yu, author Xuanchun Wang, author Fei Sun, author Yiming Li, author Linuo Zhou, author Shengmei Qin, author Zhaoyun Zhang, author Ilaria Campesi, Academic Editor
Journal Journal of Diabetes Research
Published Mar 16, 2018
DOI 10.1155/2018/9232065
Devices mentioned BK110039, K103302, K904799
Product codes mentioned FBN, NDS, PCA, KIP, KIT, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature